Are only haemophiliacs protected against ischemic heart disease? [4]

Thrombosis and Haemostasis

Volumn 92, Issue 6, 2004, Pages 1455-

  Franchini, Massimo ^a,b   Veneri, Dino ^a,b  

^a Hospital of Verona   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CHOLESTEROL; HEPARIN; PROTHROMBIN; RISTOCETIN; TICLOPIDINE; VON WILLEBRAND FACTOR;

ADULT; CASE REPORT; CIGARETTE SMOKING; CORONARY STENT; GENE MUTATION; HEART INFARCTION; HEMOPHILIA; HETEROZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LETTER; MALE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; THROMBOGENESIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VON WILLEBRAND DISEASE;

EID: 10444289697     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614306     Document Type: Letter

References (5)

1. Franchini M. Thrombotic complications in patients with hereditary bleeding disorders. Thromb Haemost 2004; 92: 298-304.
2. Franchini M, Tagliaferri A, Rossetti G, et al. Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopedic surgery without antithrombotic prophylaxis. Thromb Haemost 2004; 91: 1053-5.
3. Šrámek A, Kriek M, Rosendaal FR. Decreased mortality of ischemic heart disease among carriers of hemophilia. Lancet 2003; 362: 351-4.
4. Kiechl S, Willeit J. Cardiovascular protection in haemophilia. Lancet 2003; 362: 2026.
5. Nichols TC, Samana CM, Bellinger DA, et al. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA 1995; 92: 2455-9.